Connect with us

INDUSTRIAL HEMP

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Published

on

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the CA-170 study. CA-170 is a dual inhibitor of PD1 and VISTA that gets administered orally, and Curis believe that the drug could be beneficial in the treatment of tumors that express high levels of VISTA. VISTA is shown in over 90% of the mesothelioma cells.

Enrolment ahead of schedule

Curis previously announced that they were expecting to start enrolment of patients with mesothelioma in a dedicated cohort within the on-going first phase of the study.  Speaking on the progress that they have made, the CEO and President of Curis, James Dentzer, stated that they were pleased to announce the start of dosing in the CA-170 which he says is ahead of schedule.

During the last quarter’s earnings conference call, he said the company outlined the reorganization of their resources with a focus in strengthening their clinical execution. He adds that the announcement on the progress is a result of the efforts they have put in place and he reiterated that they are confident in their expectation to provide preliminary efficacy data by the second half of the year.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

Positive preliminary CA-170 results

The company says that CA-170 is the only anti-VISTA therapeutic that is currently under evaluation in clinical trials. CA-170 has shown promising results in that it demonstrated encouraging safety and tolerability and also its preliminary anti-tumor activity has been favorable in various patients in different types of tumors. The first phase of the study is the CA-170 clinical trial that is targeting patient population that has shown high expression levels of VISTA. VISTA is considered to be a resistance mechanism in anti-PD1 Antibodies treatment in melanoma as well as in prostate cancer among other cancers.

The first phase will be an open-label dose escalation and expansion trial that will evaluate safety pharmacodynamics and pharmacokinetics as well as the clinical effects of CA-170 in patients with lymphomas and advanced tumors. Administration of CA-170 shall be in two dose levels in the evaluation of the dedicated mesothelioma cohort.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         
Continue Reading

TRENDING STORIES

INDUSTRIAL HEMP2 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...

INDUSTRIAL HEMP2 months ago

Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...

INDUSTRIAL HEMP2 months ago

Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....

INDUSTRIAL HEMP2 months ago

Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...

INDUSTRIAL HEMP2 months ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...

INDUSTRIAL HEMP2 months ago

Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...

INDUSTRIAL HEMP2 months ago

CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...

INDUSTRIAL HEMP2 months ago

Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...

INDUSTRIAL HEMP2 months ago

Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...

INDUSTRIAL HEMP2 months ago

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...

Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play